IGF2BP1 and cancer: We have performed a multi-omic analysis to identify changes in direct RNA binding sites (eCLIP), RNA expression (RNAseq), and protein expression (Mass spectrometry), thereby revealing the global effect of the inhibitor on cancer progression, and have identified novel mechanisms through which IGF2BP1 influences LUAD.